Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Protein drink may help seniors regain strength and independence

NCT ID NCT07322653

Symptom relief Sponsor: Nuritas Ltd Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a special protein drink called MediDrink Platinum+ can improve muscle strength, physical function, and overall well-being in adults aged 60 and older who have muscle loss (sarcopenia) and are malnourished. Participants will take the drink alone or with an added protein ingredient for 12 weeks. The goal is to see if it helps them perform daily activities more easily and regain independence.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 75 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 60 years or older * BMI ≤ 25 kg/m² * Malnourished (mini nutritional assessment MNA \<11 * Sarcopenic: SARC-F score ≥ 4 * Capable or oral feeding either alone or assisted * Ambulatory (WHO PS/ECOG 0-3) * Ability to complete questionnaires and self assess health status * Ability to provide consent Exclusion Criteria: * Patient cannot eat orally * Acute Infection * Proven Intestinal obstruction * Co-morbidities requiring a special diet (diabetes, kidney disease etc.) * Liver dysfunction * Acute or chronic renal failure * Uncontrollable nausea or vomiting * Use of megestrol acetate or metabolic steroids * Dietary supplement use in the last 3 months * Known intolerance or allergy to the investigational products * Participation in any clinical trial within the last 3 months

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Malnourished are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Malnutrition nutritional deficiency disease Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Malnourished Muscle mass Physical function Protein supplementation Sarcopenia in elderly Strength

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    2 sites. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Országos Korányi Pulmonológiai Intézet

    RECRUITING

    Budapest, 1121, Hungary

  • Sóstói Szivárvány Idősek Otthona

    RECRUITING

    Nyíregyháza, 4431, Hungary

More trials for these conditions

Other studies related to the condition(s) this trial covers.